Syndax Pharmaceuticals grants inducement awards for up to 175,000 shares
Syndax Pharmaceuticals announced inducement grants under NASDAQ Listing Rule 5635(c)(4) on Sept. 1, 2026, to purchase up to 175,000 shares of common stock.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.